Showing results (111-120 of 219) with videos related to
Sort By:
Pageof 22
Blood Cell Therapy|July 19, 2023
Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case reportKeiichi Nakata, Shigeo Fuji, Midori Koike, et al.Bone Marrow Transplantation|February 21, 2018
The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemiaKiyosumi Ochi, Shigeo Fuji, Kuniko Takano, et al.Bone Marrow Transplantation|March 11, 2018
Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphomaYoshitaka Inoue, Shigeo Fuji, Ryuji Tanosaki, et al.International Journal of Hematology|October 5, 2013
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 casesShigeo Fuji, Niina Ueno, Nobuhiro Hiramoto, et al.Annals of Hematology|September 29, 2018
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphomaHiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, et al.Bone Marrow Transplantation|January 22, 2019
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysisShigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese PatientsReiko Ito, Yoshihiro Inamoto, Yoshitaka Inoue, et al.Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|September 23, 2016
Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016Anca Bojan, Ioana Berindan-Neagoe, S Ciurea, et al.Scientific Reports|August 11, 2023
Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activitySuguru Tamura, Hajime Ishiguro, Tatsuya Suwabe, et al.European Journal of Immunology|February 24, 2025
Trametinib Suppresses the Stimulated T Cells Through G1 Arrest and ApoptosisToshimasa Nakao, Takero Shindo, Hideki Takakura, et al.Pageof 22